<DOC>
	<DOCNO>NCT00798473</DOCNO>
	<brief_summary>Background : - Up 30 % child adolescents Crohn 's disease decrease bone strength , decrease bone density , call osteopenia . - Bisphosphonates group drug well study find effective treatment osteopenia menopausal woman . - Zoledronate potent third generation bisphosphonate , safe easy administer , find effective treatment menopausal woman osteopenia . Hypothesis : The investigator hypothesize zoledronate improve bone density child adolescents Crohn 's disease osteopenia .</brief_summary>
	<brief_title>Zoledronate Osteopenia Pediatric Crohn 's</brief_title>
	<detailed_description>- This study recruit 40 child adolescent , age 6 18 , proven abnormal bone density measure special type x-ray call DEXA-scan . - Participants allocate random one two group : either treatment zoledronate , placebo . - Neither participant physician aware group participant . - Participants follow every three month one year , assess blood test , urine test , physical examination , diet questionnaire exercise questionnaire . - Participants repeat DEXA scan 6 12 month begin study . - Once participant enrol follow one whole year , compare bone density group treat zoledronate group treat placebo .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>patient age 6 18 , diagnose Crohn 's disease osteopenia , minimum 6 month adequate calcium vitamin D intake . ( Osteopenia define purpose study : Zscore lumber spine BMD DEXA 2.0 less , 1.5 risk factor ( either steroid use 6 month decrease 0.5 zscore precede 12 month ) . ) renal dysfunction , insufficient calcium vitamin D intake , current medication condition affect bone metabolism , documented fracture , previously diagnose bone disease , document intolerance/hypersensitivity bisphosphonates , previous treatment bisphosphonates within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Bisphosphonates</keyword>
	<keyword>Zoledronate</keyword>
</DOC>